One of the most consistent findings in aesthetic medicine research is also one of the most commonly overlooked in practice: the quality of a patient's daily skincare significantly amplifies the results of every injectable or device treatment they receive. Clinical data on the Obagi Nu-Derm system makes this case with unusual clarity — and it has implications for how seriously we should all take the products we put on our skin.
Medical-Grade Versus Over-the-Counter
The distinction between over-the-counter (OTC) and medical-grade skincare is not one of marketing. It is one of formulation depth, active ingredient concentration, and clinical testing. OTC skincare products are formulated to act on the skin's surface — within the stratum corneum — because they cannot legally claim to affect deeper structures without crossing the regulatory boundary into medicines. Medical-grade products, prescribed through a clinical setting, can contain active ingredients at concentrations proven to act at the cellular level.
The Obagi Nu-Derm system — created by Dr Zein Obagi and the best-selling medical skin programme in the United States — is the clearest example of this distinction in practice. Its multi-step daily protocol uses prescription-strength tretinoin (a retinoid) and, in its original formulation, hydroquinone (a melanogenesis inhibitor), to work at the cellular level by accelerating skin cell turnover and regulating melanin production. The system is prescribed and monitored by a healthcare professional, not purchased from a pharmacy shelf.
What the Clinical Data Shows
In a published clinical study, patients using the Obagi Nu-Derm system were assessed at the end of a 120-day trial. The results were striking: 82% of study participants had peers notice a positive change in their overall facial appearance, compared to 16% in the standard skincare control group. At the end of the trial, 89% of Nu-Derm patients reported being satisfied or extremely satisfied with their overall facial appearance, versus 12% in the control group.
Separate research examined the combination of Nu-Derm with Botox injections. Patients who used Nu-Derm alongside anti-wrinkle treatment reported significantly higher satisfaction than those receiving Botox with a placebo skincare product, and showed greater measured improvement in overall facial appearance. This confirms what experienced aesthetic practitioners have long observed: well-prepared skin amplifies every procedure performed on it.
How the 12-Week System Works
The Nu-Derm protocol consists of six products applied in a precise sequence, morning and evening. The system requires a period of adjustment — known colloquially as the "Obagi purge" — during which accelerated cell turnover temporarily causes redness, peeling, and sensitivity. This is not a sign of damage but of the system working at the intended depth. Most patients see meaningful improvement within six weeks (two complete cellular turnover cycles) and significant transformation by the end of the 12-week course.
The skin that emerges from a completed Nu-Derm programme is structurally different: more even in tone, finer in texture, more hydrated at the cellular level, and better able to sustain the results of injectable and device treatments. Tracy prescribes and monitors Obagi programmes at Cosmetica, tailoring the formulation to each patient's skin type, concerns, and treatment history. The consultation is complimentary.
The Maintenance Principle
One of the most common questions patients ask is whether they have to keep using Obagi forever to maintain their results. The honest answer is: to maintain the level of activity, yes — but the products are used at lower intensity as a maintenance programme after the initial 12 weeks. More importantly, the principle of cellular-level skincare as a foundation for aesthetic health is a permanent one. Aesthetic treatments address specific concerns; good skincare addresses the biology that generates them.